COVID-19 ScreeningNCT04538586
Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures (COVISTRESS Screening)
An observational study of COVID-19 Screening, run by University Hospital, Clermont-Ferrand at 1 site in France.
Trial summary
Coronavirus has caused containment of more than a third of the world's population. Some countries have used a major screening strategy. Screening procedures, such as waiting (or resulting) for the test, can be stressful and can attract the most stressed people. Read more about this study
- Who is it for?
- Ages 16 years and olderHealthy volunteers can take part
- Conditions the study is for
- COVID-19 Screening
- How many people
- 1,000 participants
- Where
- 1 siteFrance
- Study dates
- 1 May 2020to 1 Dec 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 years and older
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: People screened for COVID-19
Who may be able to join
- All volunteers who are screened
Who cannot join
- None
Trial locations and contacts
1 site in 1 country.
France1 site, 1 recruiting
- Recruiting
Univeristy Hospital, Clermont-Ferrand
Clermont-Ferrand, 63000
Lise LACLAUTRE, 0473754963, promo_interne_drci@chu-clermontferrand.fr
Frederic DUTHEIL
About this study
Official title: Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures
Coronavirus has caused containment of more than a third of the world's population. Some countries have used a major screening strategy. Screening procedures, such as waiting (or resulting) for the test, can be stressful and can attract the most stressed people. However, there is currently no data on the relationship between stress and screening for SARS-CoV2
Read the detailed description
This is an observational study by REDCap questionnaire® via a flyer deposited in the waiting room of the COVID screening centres. No incentive to complete the questionnaire will be made. The self-survey will assess stress and its relationship to SARS-CoV2 screening procedures, socio-demographic factors or lifestyle habits. This Screening questionnaire includes 31 questions.
- Conditions
- COVID-19 Screening
- Keywords
- COVID-19, Screening, Stress
- Medical subject headings
- COVID-19
What is being measured
The primary outcome is the main question the study is designed to answer.
Stress measures
Attitudes and stress related to screening procedure will be measured via questionnaire
Measured: Day 1
Secondary outcomes (2)
Screening
Attitudes towards screening will be measured via questionnaire
Measured: Day 1
Sociodemographic characteristics
Age, gender, qualification, personal work status, ethnicity, life characteristics and stress will be assessed by questionnaires
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Sep 2020
- Study start1 May 2020
- Primary completion1 Dec 2020 (estimated)
- Study completion1 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for COVID-19 ScreeningStudies of the same condition, open and under way.
- More trials run by University Hospital, Clermont-FerrandThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04538586
- Sponsor's protocol ID
- 2020 COVISTRESS Screening
- Status last verified
- Sep 2020
- First submitted
- 3 Sep 2020
- Last updated
- 4 Sep 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Nasir H, Duclos M, Pereira B, Thivel D, Jiao J, Quach B, Bagheri R, Zak M, Ugbolue UC, Baker JS, Cole A, Mermillod M, Charkhabi M; COVISTRESS network; Clinchamps M, Dutheil F. Teleworking as the main risk factor for sedentary behavior: the COVISTRESS international study. PLoS One. 2026 Sep 10;21(9):e0356764. doi: 10.1371/journal.pone.0356764. eCollection 2026.
PubMed 42721213Delamarre L, Tannous S, Lakbar I, Couarraze S, Pereira B, Leone M, Marhar F, Baker JS, Bagheri R, Berton M, Rabbouch H, Zak M, Sikorski T, Wasik M, Nasir H, Quach B, Jiao J, Aviles R, Covistress Network, Clinchamps M, Dutheil F. The Evolution of Effort-Reward Imbalance in Workers during the COVID-19 Pandemic in France-An Observational Study in More than 8000 Workers. Int J Environ Res Public Health. 2022 Jul 26;19(15):9113. doi: 10.3390/ijerph19159113.
PubMed 35897478
Study at a glance
From the registry record, last updated by the sponsor on 4 Sep 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures
- ClinicalTrials.gov ID
- NCT04538586
- Acronym / sponsor ID
- 2020 COVISTRESS Screening
- Conditions
- COVID-19 Screening
- Keywords
- COVID-19, Screening, Stress
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- University Hospital, Clermont-FerrandUniversity, hospital or other
- Study start
- 1 May 2020 (actual)
- Primary completion
- 1 Dec 2020 (estimated)
- Study completion
- 1 Dec 2025 (estimated)
- First posted
- 4 Sep 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Coronavirus has caused containment of more than a third of the world's population. Some countries have used a major screening strategy. Screening procedures, such as waiting (or resulting) for the test, can be stressful and can attract the most stressed people. However, there is currently no data on the relationship between stress and screening for SARS-CoV2
Detailed description
This is an observational study by REDCap questionnaire® via a flyer deposited in the waiting room of the COVID screening centres. No incentive to complete the questionnaire will be made. The self-survey will assess stress and its relationship to SARS-CoV2 screening procedures, socio-demographic factors or lifestyle habits. This Screening questionnaire includes 31 questions.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 16 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- People screened for COVID-19
Key inclusion criteria (1 listed)
- All volunteers who are screened
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Stress measures
Time frame: Day 1
Attitudes and stress related to screening procedure will be measured via questionnaire
2 secondary outcomes
Screening
Time frame: Day 1
Sociodemographic characteristics
Time frame: Day 1
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Sep 2020.
- Derived from this study: PubMed 42721213Nasir H, Duclos M, Pereira B, Thivel D, Jiao J, Quach B, Bagheri R, Zak M, Ugbolue UC, Baker JS, Cole A, Mermillod M, Charkhabi M; COVISTRESS network; Clinchamps M, Dutheil F. Teleworking as the main risk factor for sedentary behavior: the COVISTRESS international study. PLoS One. 2026 Sep 10;21(9):e0356764. doi: 10.1371/journal.pone.0356764. eCollection 2026.
- Derived from this study: PubMed 35897478Delamarre L, Tannous S, Lakbar I, Couarraze S, Pereira B, Leone M, Marhar F, Baker JS, Bagheri R, Berton M, Rabbouch H, Zak M, Sikorski T, Wasik M, Nasir H, Quach B, Jiao J, Aviles R, Covistress Network, Clinchamps M, Dutheil F. The Evolution of Effort-Reward Imbalance in Workers during the COVID-19 Pandemic in France-An Observational Study in More than 8000 Workers. Int J Environ Res Public Health. 2022 Jul 26;19(15):9113. doi: 10.3390/ijerph19159113.
Related trials for COVID-19 Screening
Active, not recruiting
Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19
Tuberculosis, COVID-19
Not yet recruiting
Volatile Organic Compounds Analysis by PTR-TOF-MS for Screening Respiratory Infections Using Exhaled Breath.
COVID-19 Infections, Respiratory Infections, Acute
RecruitingObservational study
Hiccups and Obstacles Of E-Learning Among Medical Sudents
Covid-19, E-learning
RecruitingObservational study
Screening for Malnutrition in Obese Patients
Overweight and Obese Adults, Malnutrition or Risk of Malnutrition
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of COVID-19 Screening, run by University Hospital, Clermont-Ferrand at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 4 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Lise LACLAUTRE (0473754963, promo_interne_drci@chu-clermontferrand.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Stress measures (time frame: Day 1). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04538586, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2020.